Tomoya Watanabe

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “E4 engages uPAR and enolase-1 and activates urokinase to exert antifibrotic effects”.

E4 engages uPAR and enolase-1 and activates urokinase to exert antifibrotic effects

JCI Insight(2021)10.1172/jci.insight.144935

N/A

0DataRank · unranked

23 citations

Tomoya Watanabe, Tetsuya NISHIMOTO, Takahisa Takihara, Logan Mlakar, Xinh-Xinh Nguyen +5 more

Ameliorating Fibrosis in Murine and Human Tissues with END55, an Endostatin-Derived Fusion Protein Made in Plants

Biomedicines(2022)10.3390/biomedicines10112861

N/A

0DataRank · unranked

5 citations

Sara M. Garrett, Tomoya Watanabe, Matthew Sanderson, Tetsuya NISHIMOTO, Jonathan Heywood +5 more

A water-soluble caveolin-1 peptide inhibits psoriasis-like skin inflammation by suppressing cytokine production and angiogenesis

Scientific Reports(2024)10.1038/s41598-024-71350-1

N/A

0DataRank · unranked

3 citations

Naoko Takamura, Tomoya Watanabe, Miho Asami, Noriko Ikeda, Charles Reese +3 more